{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:55:03Z","timestamp":1768712103608,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Minnesota Academic Health Center Faculty Development Grant","award":["FRD #09-18"],"award-info":[{"award-number":["FRD #09-18"]}]},{"name":"University of Minnesota Academic Health Center Faculty Development Grant","award":["FRD #09-18"],"award-info":[{"award-number":["FRD #09-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40263-015-0300-9","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T14:03:01Z","timestamp":1450188181000},"page":"1041-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy"],"prefix":"10.1007","volume":"29","author":[{"given":"Reena V.","family":"Kartha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"300_CR1","doi-asserted-by":"crossref","unstructured":"Santosh Rai PV, Suresh BV, Bhat IG, Sekhar M, Chakraborti S. Childhood adrenoleukodystrophy\u2014classic and variant\u2014review of clinical manifestations and magnetic resonance imaging. J Pediatr Neurosci. 2013;8(3):192\u20137. doi: 10.4103\/1817-1745.123661 .","DOI":"10.4103\/1817-1745.123661"},{"issue":"1","key":"300_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","volume":"1688","author":"CR Vargas","year":"2004","unstructured":"Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2004;1688(1):26\u201332. doi: 10.1016\/j.bbadis.2003.10.004 .","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"300_CR3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","volume":"64","author":"JM Powers","year":"2005","unstructured":"Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64(12):1067\u201379. doi: 10.1097\/01.jnen.0000190064.28559.a4 .","journal-title":"J Neuropathol Exp Neurol"},{"key":"300_CR4","author":"M Deon","year":"2015","unstructured":"Deon M, Marchetti DP, Donida B, Wajner M, Vargas C. Oxidative stress in patients with X-linked adrenoleukodystrophy. Cell Mol Neurobiol. 2015. doi: 10.1007\/s10571-015-0234-2 (Epub 2015 Jul 14).","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"300_CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymgme.2013.05.009","volume":"109","author":"S Petrillo","year":"2013","unstructured":"Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, et al. Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Mol Genet Metab. 2013;109(4):366\u201370. doi: 10.1016\/j.ymgme.2013.05.009 .","journal-title":"Mol Genet Metab"},{"issue":"Pt 12","key":"300_CR6","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/brain\/aws292","volume":"135","author":"J Lopez-Erauskin","year":"2012","unstructured":"Lopez-Erauskin J, Galino J, Bianchi P, Fourcade S, Andreu AL, Ferrer I, et al. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain. 2012;135(Pt 12):3584\u201398. doi: 10.1093\/brain\/aws292 .","journal-title":"Brain."},{"issue":"4","key":"300_CR7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26(4):851\u201360.","journal-title":"J Neurochem"},{"issue":"3","key":"300_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00043426-199805000-00013","volume":"20","author":"J Kapelushnik","year":"1998","unstructured":"Kapelushnik J, Varadi G, Nagler A. Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy. J Pediatr Hematol Oncol. 1998;20(3):257\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"300_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1005656029200","volume":"23","author":"Y Suzuki","year":"2000","unstructured":"Suzuki Y, Isogai K, Teramoto T, Tashita H, Shimozawa N, Nishimura M, et al. Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis. 2000;23(5):453\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"300_CR10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1399-0012.2005.00411.x","volume":"19","author":"IB Resnick","year":"2005","unstructured":"Resnick IB, Abdul Hai A, Shapira MY, Bitan M, Hershkovitz E, Schwartz A, et al. Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen. Clin Transplant. 2005;19(6):840\u20137. doi: 10.1111\/j.1399-0012.2005.00411.x .","journal-title":"Clin Transplant"},{"issue":"5","key":"300_CR11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.tp.0000181457.43146.36","volume":"81","author":"O Ringden","year":"2006","unstructured":"Ringden O, Remberger M, Svahn BM, Barkholt L, Mattsson J, Aschan J, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center. Transplantation. 2006;81(5):718\u201325. doi: 10.1097\/01.tp.0000181457.43146.36 .","journal-title":"Transplantation"},{"issue":"6","key":"300_CR12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbmt.2007.01.082","volume":"13","author":"D Beam","year":"2007","unstructured":"Beam D, Poe MD, Provenzale JM, Szabolcs P, Martin PL, Prasad V, et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant. 2007;13(6):665\u201374. doi: 10.1016\/j.bbmt.2007.01.082 .","journal-title":"Biol Blood Marrow Transplant."},{"issue":"7","key":"300_CR13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","volume":"118","author":"WP Miller","year":"2011","unstructured":"Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS, et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011;118(7):1971\u20138. doi: 10.1182\/blood-2011-01-329235 .","journal-title":"Blood"},{"issue":"4","key":"300_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1705571","volume":"39","author":"J Tolar","year":"2007","unstructured":"Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-Acetyl-l-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007;39(4):211\u20135. doi: 10.1038\/sj.bmt.1705571 .","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"300_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","volume":"60","author":"M Zafarullah","year":"2003","unstructured":"Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003;60(1):6\u201320.","journal-title":"Cell Mol Life Sci"},{"key":"300_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijdevneu.2015.03.004","volume":"43","author":"DP Marchetti","year":"2015","unstructured":"Marchetti DP, Donida B, da Rosa HT, Manini PR, Moura DJ, Saffi J, et al. Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients. Int J Dev Neurosci. 2015;43:8\u201315. doi: 10.1016\/j.ijdevneu.2015.03.004 .","journal-title":"Int J Dev Neurosci"},{"issue":"8","key":"300_CR17","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2010.3877","volume":"15","author":"J Galino","year":"2011","unstructured":"Galino J, Ruiz M, Fourcade S, Schluter A, Lopez-Erauskin J, Guilera C, et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal. 2011;15(8):2095\u2013107. doi: 10.1089\/ars.2010.3877 .","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"300_CR18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","volume":"70","author":"J Lopez-Erauskin","year":"2011","unstructured":"Lopez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A, Naudi A, et al. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol. 2011;70(1):84\u201392. doi: 10.1002\/ana.22363 .","journal-title":"Ann Neurol."},{"issue":"12","key":"300_CR19","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","volume":"17","author":"S Fourcade","year":"2008","unstructured":"Fourcade S, Lopez-Erauskin J, Galino J, Duval C, Naudi A, Jove M, et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet. 2008;17(12):1762\u201373. doi: 10.1093\/hmg\/ddn085 .","journal-title":"Hum Mol Genet"},{"key":"300_CR20","unstructured":"Masonic Cancer Center, University of Minnesota. Treatment of high risk, inherited lysosomal and peroxisomal disorders by reduced intensity hematopoietic stem cell transplantation [ClinicalTrials.gov identifier NCT00383448]. US National Institutes of Health, ClinicalTrials.gov. https:\/\/www.clinicaltrials.gov . Accessed 25 Nov 2015."},{"issue":"3","key":"300_CR21","doi-asserted-by":"crossref","first-page":"e32223","DOI":"10.1371\/journal.pone.0032223","volume":"7","author":"W Bao","year":"2012","unstructured":"Bao W, Rong S, Zhang M, Yu X, Zhao Y, Xiao X, et al. Plasma heme oxygenase-1 concentration in relation to impaired glucose regulation in a non-diabetic Chinese population. PLoS One. 2012;7(3):e32223. doi: 10.1371\/journal.pone.0032223 .","journal-title":"PLoS One"},{"issue":"1","key":"300_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000357871","volume":"4","author":"IF Billings","year":"2014","unstructured":"Billings IF, Yu C, Byrne JG, Petracek MR, Pretorius M. Heme oxygenase-1 and acute kidney injury following cardiac surgery. Cardiorenal Med. 2014;4(1):12\u201321. doi: 10.1159\/000357871 .","journal-title":"Cardiorenal Med."},{"issue":"2","key":"300_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0404.2009.01261.x","volume":"121","author":"I Mateo","year":"2010","unstructured":"Mateo I, Infante J, Sanchez-Juan P, Garcia-Gorostiaga I, Rodriguez-Rodriguez E, Vazquez-Higuera JL, et al. Serum heme oxygenase-1 levels are increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Acta Neurol Scand. 2010;121(2):136\u20138. doi: 10.1111\/j.1600-0404.2009.01261.x .","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"300_CR24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/clpt.2009.221","volume":"87","author":"AE Bharucha","year":"2010","unstructured":"Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, et al. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther. 2010;87(2):187\u201390. doi: 10.1038\/clpt.2009.221 .","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"300_CR25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri KR, Mantovani JJ, Herzenberg LA. N-Acetylcysteine\u2014a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355\u20139. doi: 10.1016\/j.coph.2007.04.005 .","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"300_CR26","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/jps.24482","volume":"104","author":"J Zhou","year":"2015","unstructured":"Zhou J, Coles LD, Kartha RV, Nash N, Mishra U, Lund TC, et al. Intravenous administration of stable-labeled N-acetylcysteine demonstrates an indirect mechanism for boosting glutathione and improving redox status. J Pharm Sci. 2015;104(8):2619\u201326. doi: 10.1002\/jps.24482 .","journal-title":"J Pharm Sci"},{"issue":"12","key":"300_CR27","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1002\/jps.23325","volume":"101","author":"KK Radtke","year":"2012","unstructured":"Radtke KK, Coles LD, Mishra U, Orchard PJ, Holmay M, Cloyd JC. Interaction of N-acetylcysteine and cysteine in human plasma. J Pharm Sci. 2012;101(12):4653\u20139. doi: 10.1002\/jps.23325 .","journal-title":"J Pharm Sci"},{"issue":"3","key":"300_CR28","first-page":"301","volume":"20","author":"P Ewing","year":"2007","unstructured":"Ewing P, Hildebrandt GC, Planke S, Andreesen R, Holler E, Gerbitz A. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation. Int J Mol Med. 2007;20(3):301\u20138.","journal-title":"Int J Mol Med"},{"issue":"7","key":"300_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbmt.2004.04.001","volume":"10","author":"A Gerbitz","year":"2004","unstructured":"Gerbitz A, Ewing P, Wilke A, Schubert T, Eissner G, Dietl B, et al. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2004;10(7):461\u201372. doi: 10.1016\/j.bbmt.2004.04.001 .","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"300_CR30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.humimm.2006.03.006","volume":"67","author":"FH Bach","year":"2006","unstructured":"Bach FH. Heme oxygenase-1 and transplantation tolerance. Hum Immunol. 2006;67(6):430\u20132. doi: 10.1016\/j.humimm.2006.03.006 .","journal-title":"Hum Immunol"},{"issue":"2","key":"300_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2012.03.019","volume":"106","author":"FJ Rockenbach","year":"2012","unstructured":"Rockenbach FJ, Deon M, Marchese DP, Manfredini V, Mescka C, Ribas GS, et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. Mol Genet Metab. 2012;106(2):231\u20136. doi: 10.1016\/j.ymgme.2012.03.019 .","journal-title":"Mol Genet Metab"},{"issue":"5","key":"300_CR32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/156720509789207985","volume":"6","author":"HM Schipper","year":"2009","unstructured":"Schipper HM, Gupta A, Szarek WA. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr Alzheimer Res. 2009;6(5):424\u201330. doi: 10.2174\/156720509789207985 .","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"300_CR33","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/1097-0142(19870901)60:5<1127::AID-CNCR2820600535>3.0.CO;2-A","volume":"60","author":"R Or","year":"1987","unstructured":"Or R, Matzner Y, Konijn AM. Serum ferritin in patients undergoing bone marrow transplantation. Cancer. 1987;60(5):1127\u201331.","journal-title":"Cancer"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0300-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0300-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0300-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:25Z","timestamp":1559504485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0300-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0300-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}